Amdocs (DOX) Stock
Amdocs's price implies about -9% free cash flow growth a year.
Key numbers
- P/E (trailing)
- 8.33x
- P/E (forward)
- 6.30x
- Revenue growth
- -9.4%
- Operating margin
- 16.1%
- Debt / equity
- 0.19x
What Amdocs's price implies
From a reverse DCF on Amdocs's SEC filings.
- Free cash flow, last 9 years
- 3.1%a year
- Revenue, same period
- 2.2%a year
At a market value of $4.6B, Amdocs's free cash flow of $645M (fiscal 2025) would need to grow about -9% a year for the stock to be worth today's price. That is slower than the company has grown its free cash flow over the last 9 years. A 9% discount rate and 3% growth after year 10 (how it works). Change them in the Modeling tab or the reverse DCF calculator.
Revenue and free cash flow
Fiscal years, from Amdocs's 10-K filings.
Amdocs revenue and free cash flow
FY2016–FY2025Results from SEC filings
All three statements · Quarters, TTM and 20+ years of statements in Investingly
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $4.3B | $4.6B | $4.9B | $5.0B | $4.5B |
| Net income | $688M | $550M | $541M | $493M | $565M |
| Free cash flow | $715M | $530M | $698M | $619M | $645M |
| EPS (diluted) | $5.32 | $4.44 | $4.49 | $4.25 | $5.05 |
| Operating margin | 14.0% | 14.5% | 13.4% | 12.6% | 16.1% |
Where the revenue comes from
By products, fiscal 2025. By year
Superinvestors who own DOX
From each investor's latest 13F filing (what a 13F shows). All 18 holders
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Richard Pzena Pzena Investment Management | Added | $827M | 2.4% | Q3 2026 |
| Josef Lakonishok LSV Asset Management | Trimmed | $257M | 0.48% | Q3 2026 |
| Charles Brandes Brandes Investment Partners, LP | Trimmed | $232M | 1.6% | Q2 2026 |
| Cliff Asness AQR Capital Management | Added | $133M | 0.05% | Q2 2026 |
| Arrowstreet Capital Arrowstreet Capital | Added | $60M | 0.03% | Q2 2026 |
| Hotchkis & Wiley Hotchkis & Wiley Capital Management | Trimmed | $58M | 0.17% | Q2 2026 |
| Two Sigma Two Sigma Investments | Added | $26M | 0.02% | Q2 2026 |
| Joel Greenblatt Gotham Asset Management | Trimmed | $14M | 0.03% | Q2 2026 |
| Jim Simons Renaissance Technologies | Trimmed | $9M | 0.01% | Q2 2026 |
| Paul Marshall Marshall Wace | Added | $6M | 0.00% | Q2 2026 |
| Wasatch Wasatch Global Investors | Added | $5M | 0.04% | Q3 2026 |
| David Shaw D. E. Shaw & Co. | Trimmed | $4M | 0.00% | Q2 2026 |
Amdocs insider buying
Open-market purchases by executives and directors in the last 12 months, from SEC Form 4 filings (what insider buying tells you).
No open-market insider purchases of DOX in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.
Fundamental grade
Five factors scored 1 to 9 from DOX's latest numbers. It describes the business, not whether the stock is a buy.
Get an alert at your buy price
Free accounts get 3 price alerts.
How Amdocs compares
Amdocs's P/E is higher than 7% of Technology companies and 11% of the 2,508 companies with a P/E figure.
| Higher than | Technology | All stocks |
|---|---|---|
| P/E | 7% | 11% |
| P/FCF | 11% | 18% |
| Revenue growth | 6% | 9% |
| Operating margin | 74% | 71% |
| ROE | 70% | 75% |
Questions about Amdocs
What growth does Amdocs's stock price imply?
At a market value of $4.6B, Amdocs would need its free cash flow to grow about -9% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 3% a year.
Are Amdocs insiders buying the stock?
No open-market insider purchases of DOX in the last 12 months, according to SEC Form 4 filings.
Which superinvestors own Amdocs?
18 of the superinvestors Investingly tracks hold DOX in their latest 13F, including Richard Pzena, Josef Lakonishok, Charles Brandes.
Companies like Amdocs
Tenable Holdings Inc (TENB)$4.4BRemitly Global Inc (RELY)$4.8BPaymentus Holdings, Inc. (PAY)$4.2BWix.Com Ltd (WIX)$4.2BDlocal Ltd (DLO)$4.1BBlackBerry Ltd (BB)$5.1BCore Scientific, Inc. Common Stock (CORZ)$3.8BVaronis Systems (VRNS)$5.6BAppian Corp (APPN)$3.7B All Technology stocks→Prices and ratios as of Nov 9, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.